Andrew Xiuxuan Zhu
Massachusetts General Hospital
Collaboration graph - direct co-authors and who they connect you to
Massachusetts General Hospital
Andrew Xiuxuan Zhu (Massachusetts General Hospital) has co-authored with 769 scholars at 223 institutions, between 2007 and 2026. 270 of them within the last 4 years. Strongest collaborators, by shared papers: Lipika Goyal, Masatoshi Kudo, Richard S. Finn, Theodore Sunki Hong, David P. Ryan and Lawrence Scott Blaszkowsky. 21 scholars on JRNLClub are one introduction away.
The strongest 12 of 769, by shared papers.
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
with Masatoshi Kudo, Richard S. Finn and 3 more · 2020 · New England Journal of Medicine · 7,823 citations · DOI
AASLD guidelines for the treatment of hepatocellular carcinoma
with Richard S. Finn · 2017 · Hepatology · 4,151 citations · DOI
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
with Masatoshi Kudo, Richard S. Finn and 5 more · 2018 · The Lancet Oncology · 2,555 citations · DOI
Immunotherapies for hepatocellular carcinoma
with Josep Maria Llovet · 2021 · Nature Reviews Clinical Oncology · 1,922 citations · DOI
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
with Masatoshi Kudo, Ann-Lii Cheng and 2 more · 2021 · Journal of Hepatology · 1,883 citations · DOI
h-index 185